Gregory Jordan's Linkedin Analytics

Dr. Gregory D. Jordan is a founder and president of SeligoAI, a Student Relationship Management (SRM) solution that utilizes advanced analytics and data to guide the development of individualized learning plans and life services. This software solution enables administrators, faculty advisors, and student success staff to select the student data they need, when they need it, to make confident decisions for student success and to reach enrollment goals. SeligoAI empowers the institution to shape their student markets in alignment with their enrollment strategy. It is a comprehensive recruitment and retention ecosystem designed to support student success. He led and served King University, formerly King College, as President, October 1997-February 2014, now president emeritus, through the largest expansion program in its history, guiding its development from a baccalaureate degree granting institution to a doctoral degree granting institution. The University now offers an associate's degree, bachelor’s degrees, the MEd, MBA, MSN and DNP (2013) and is comprised of seven schools. All of these initiatives led to increased enrollment, resulting in fourteen consecutive years of record-breaking enrollment. Since 2004, the overall student body at King increased more than 1,000 students and has more than doubled since 2005 and exceeded 2700 students by 2014. The sustained increases in enrollment were accompanied by the expansion of the institution’s technology infrastructure. Online programs represented the fastest growing platform of the institution. Dr. Jordan served on SACSCOC, the Southern Association of Colleges and Schools, Commission on Colleges, Peer Review Board, and served on the SACSCOC Competency-Based/Direct Assessment Committee, 2013. He also served on the Tennessee Independent Colleges and Universities Association Board of Directors, the Kingsport Center for Higher Education Advisory Board, the Kingsport Center for Higher Education Commission and the Board of Directors, King Pharmaceuticals, a publicly traded company on the NYSE. 2001-2010.